Search research articles
Contact Us
Filters
Showing results (11-20 of 33) with videos related to
Page
of 4
Sort By:
International Journal of Chronic Obstructive Pulmonary Disease
|
August 1, 2012
Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis
Shannon Cope, Matthias Kraemer, Jie Zhang, et al.
Current Medical Research and Opinion
|
March 12, 2015
New opportunities of real-world data from clinical routine settings in life-cycle management of drugs: example of an integrative approach in multiple sclerosis
Dietrich Rothenbacher, Gorana Capkun, Hatice Uenal, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
June 24, 2011
Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease--a network meta-analysis
Shannon Cope, Gorana Capkun-Niggli, Rupert Gale, et al.
Therapeutic Innovation & Regulatory Science
|
April 23, 2025
Assessing the Value of Integrated Evidence Approaches in Drug Development
Joseph A DiMasi, Melvin Skip Olson, Zachary Smith, et al.
Respiratory Research
|
April 12, 2011
Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review
Marie Westwood, Jean Bourbeau, Paul W Jones, et al.
Muscle & Nerve
|
May 12, 2017
Burden of illness and healthcare resource use in United States patients with sporadic inclusion body myositis
Gorana Capkun, Aoife Callan, Haijun Tian, et al.
Contemporary Clinical Trials
|
July 19, 2011
Application of latent growth and growth mixture modeling to identify and characterize differential responders to treatment for COPD
Donald E Stull, Ingela Wiklund, Rupert Gale, et al.
BMC Medical Research Methodology
|
April 19, 2015
Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertension
Howard H Z Thom, Gorana Capkun, Annamaria Cerulli, et al.
Theoretical Biology & Medical Modelling
|
November 8, 2019
Development and validation of a Bayesian survival model for inclusion body myositis
Gorana Capkun, Jens Schmidt, Shubhro Ghosh, et al.
Current Alzheimer Research
|
October 9, 2020
Modelling Decline in Cognition to Decline in Function in Alzheimer's Disease
Helene Karcher, Marina Savelieva, Luyuan Qi, et al.
Page
of 4
Search research articles
Search
Showing results (11-20 of 33) with videos related to
Sort By:
Page
of 4
International Journal of Chronic Obstructive Pulmonary Disease
|
August 1, 2012
Efficacy of indacaterol 75 μg versus fixed-dose combinations of formoterol-budesonide or salmeterol-fluticasone for COPD: a network meta-analysis
Shannon Cope, Matthias Kraemer, Jie Zhang, et al.
Current Medical Research and Opinion
|
March 12, 2015
New opportunities of real-world data from clinical routine settings in life-cycle management of drugs: example of an integrative approach in multiple sclerosis
Dietrich Rothenbacher, Gorana Capkun, Hatice Uenal, et al.
International Journal of Chronic Obstructive Pulmonary Disease
|
June 24, 2011
Comparative efficacy of indacaterol 150 μg and 300 μg versus fixed-dose combinations of formoterol + budesonide or salmeterol + fluticasone for the treatment of chronic obstructive pulmonary disease--a network meta-analysis
Shannon Cope, Gorana Capkun-Niggli, Rupert Gale, et al.
Therapeutic Innovation & Regulatory Science
|
April 23, 2025
Assessing the Value of Integrated Evidence Approaches in Drug Development
Joseph A DiMasi, Melvin Skip Olson, Zachary Smith, et al.
Respiratory Research
|
April 12, 2011
Relationship between FEV1 change and patient-reported outcomes in randomised trials of inhaled bronchodilators for stable COPD: a systematic review
Marie Westwood, Jean Bourbeau, Paul W Jones, et al.
Muscle & Nerve
|
May 12, 2017
Burden of illness and healthcare resource use in United States patients with sporadic inclusion body myositis
Gorana Capkun, Aoife Callan, Haijun Tian, et al.
Contemporary Clinical Trials
|
July 19, 2011
Application of latent growth and growth mixture modeling to identify and characterize differential responders to treatment for COPD
Donald E Stull, Ingela Wiklund, Rupert Gale, et al.
BMC Medical Research Methodology
|
April 19, 2015
Network meta-analysis combining individual patient and aggregate data from a mixture of study designs with an application to pulmonary arterial hypertension
Howard H Z Thom, Gorana Capkun, Annamaria Cerulli, et al.
Theoretical Biology & Medical Modelling
|
November 8, 2019
Development and validation of a Bayesian survival model for inclusion body myositis
Gorana Capkun, Jens Schmidt, Shubhro Ghosh, et al.
Current Alzheimer Research
|
October 9, 2020
Modelling Decline in Cognition to Decline in Function in Alzheimer's Disease
Helene Karcher, Marina Savelieva, Luyuan Qi, et al.
Page
of 4